QcrC is a potential target for antibody therapy and vaccination to control Campylobacter jejuni infection by suppressing its energy metabolism.
Hosomi K, Hatanaka N, Hinenoya A, Adachi J, Tojima Y, Furuta M, Uchiyama K, Morita M, Nagatake T, Saika A, Kawai S, Yoshii K, Kondo S, Yamasaki S, Kunisawa J.
Hosomi K, et al. Among authors: saika a.
Front Microbiol. 2024 Jul 2;15:1415893. doi: 10.3389/fmicb.2024.1415893. eCollection 2024.
Front Microbiol. 2024.
PMID: 39015740
Free PMC article.